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ABSTRACT
Streptococcus pyogenes is a human pathogen responsible for a wide spectrum of diseases ranging
from mild to life-threatening infections. During the infectious process, the temporal and spatial
expression of pathogenicity factors is tightly controlled by a complex network of protein and RNA
regulators acting in response to various environmental signals. Here, we focus on the class of small
RNA regulators (sRNAs) and present the first complete analysis of sRNA sequencing data in
S. pyogenes. In the SF370 clinical isolate (M1 serotype), we identified 197 and 428 putative
regulatory RNAs by visual inspection and bioinformatics screening of the sequencing data,
respectively. Only 35 from the 197 candidates identified by visual screening were assigned a
predicted function (T-boxes, ribosomal protein leaders, characterized riboswitches or sRNAs),
indicating how little is known about sRNA regulation in S. pyogenes. By comparing our list of
predicted sRNAs with previous S. pyogenes sRNA screens using bioinformatics or microarrays, 92
novel sRNAs were revealed, including antisense RNAs that are for the first time shown to be
expressed in this pathogen. We experimentally validated the expression of 30 novel sRNAs and
antisense RNAs. We show that the expression profile of 9 sRNAs including 2 predicted regulatory
elements is affected by the endoribonucleases RNase III and/or RNase Y, highlighting the critical role






pyogenes; small RNAs; T-
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Introduction
Regulatory RNAs are present in all kingdoms of life. In
bacteria, the family of small RNAs (sRNAs) is typically
composed of 50 to 300 nucleotide (nt) long transcripts.
Bacterial sRNAs can modulate gene expression through
a diversity of mechanisms; for example they can control
adaptive responses and play critical roles in metabolic
and virulence pathways.1-6 Although mostly character-
ized in Gram-negative bacteria, novel mechanisms of
sRNA action were recently discovered in Gram-positive
bacteria.7 sRNA-driven regulations include mechanisms
at the transcriptional, post-transcriptional, translational
and post-translational levels. While some regulatory
RNAs bind target proteins, most of the investigated
sRNAs have been shown to act directly on RNA targets.
RNA-targeting sRNAs can act in cis at the level of their
own locus.8,9 For example, riboswitches respond to intra-
cellular concentrations of metabolites, and antisense
RNAs (asRNAs) are encoded on the opposite strand of
their RNA targets sharing long, 100% complementary
stretches.10 RNA-targeting sRNAs can also act in trans at
the post-transcriptional level usually by base pairing
with mRNA targets encoded from other loci through
complementarity over a small region of 6 to 8 nt.8
Another family of sRNAs consists of the CRISPR RNAs
(crRNAs) involved in bacterial and archaeal adaptive
immunity against mobile genetic elements. In the inter-
ference stage of the immunity, mature short crRNAs
guide single or complexed CRISPR-associated (Cas) pro-
tein(s) to target invading DNA or RNA.11
The genome of the M1 clinical isolate SF370 of the
human pathogen S. pyogenes is 1852441 bp in size, of
which 15% consist of intergenic regions (IGRs).12
Computational predictions of sRNAs in this pathogen
were done previously using sRNApredict,13,14 SIPHT,15
sRNA scanner in SF370,16 MOSES in M49 GAS17 and
sRNAPredict, eQRNA and RNAz in MGAS315.18 Three
experimental searches for sRNAs in M1T1GAS
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(MGAS2221)19 and M49GAS20 using microarrays, in
SF370 using the 454 RNA sequencing technology21 and
in M1T1GAS (MGAS2221) using Illumina RNA
sequencing22 were also performed. The microarray
screens19,20 and computational predictions13–16,18 of
sRNAs were further analyzed whereas the RNA sequenc-
ing analyses were only presented as raw data.21,22 A large
number of novel putative sRNAs in S. pyogenes are now
available for analysis in phenotypic and mechanistic
studies (for details on sRNAs with known regulatory
functions in S. pyogenes, see ref.23). Remarkably, none of
the published screens of predicted or validated sRNAs in
S. pyogenes have reported asRNA expression in this path-
ogen, most probably because the performed microarray
analyses could reveal only sRNAs encoded within
IGRs.24
Until now, only a few sRNAs have been studied in
detail in S. pyogenes. Pel/sagA RNA (pleiotropic effect
locus/streptolysin-associated gene A) and RivX RNA
play critical roles in the expression of virulence factors,
however their direct targets still remain unknown.25,26
Pel/sagA RNA encodes the virulence factor SLS responsi-
ble for the b-hemolytic phenotype of S. pyogenes. Pel
RNA also acts as a positive regulator of virulence gene
expression and the regulation was described to be strain-
specific.25,27 RivX is an sRNA that is encoded immedi-
ately downstream of the gene encoding the response reg-
ulator RivR (RALP4, a RofA-like protein family of
transcriptional regulators) in an M6 serotype, and data
suggest that RivX corresponds to a processed form of the
rivRX transcript.26 RivR and RivX both activate the Mga
(multiple gene activator) regulon that positively controls
the expression of a number of virulence-associated regu-
lators and factors.26 The mechanism of FasX (fibronec-
tin/fibrinogen-binding/hemolytic-activity/streptokinase-
regulator-X) sRNA is well described.27–29 FasX is part of
an operon comprises genes encoding 2 putative histidine
kinases (FasBC) and one putative response regulator
(FasA).28 FasX RNA affects virulence factor expression
using 3 mechanisms. (I) FasX enhances streptokinase
virulence factor expression by stabilizing the mRNA of
the ska gene encoding streptokinase29; (II) FasX regulates
pilus expression and adherence by base pairing to the
mRNA of the pilus biosynthesis operon resulting in the
destabilization of the mRNA27 and (III) FasX inhibits
the translation of cpa mRNA encoding a pilin pro-
tein.27,30 It was recently demonstrated that regulation by
FasX sRNA is serotype-specific and depends on the pres-
ence of genes encoding FasX targets in clinical isolates.30
In addition to these S. pyogenes specific sRNAs, the fam-
ily of cia-dependent sRNAs (csRNAs), described first in
Streptococcus pneumoniae, is present in all streptococcal
genomes (with 2 to 6 csRNAs encoded per genome).31,32
In S. pneumoniae, the expression of the csRNAs is regu-
lated by the 2-component system CiaRH (Cia, Compe-
tence induction and altered cefotaxime susceptibility)
and the csRNAs inter alia target the comC mRNA
encoding the precursor of the competence stimulating
peptide (CSP).33
The first member of a novel CRISPR-associated sRNA
family, trans-activating crRNA (tracrRNA), was initially
identified in S. pyogenes and found associated to the type
II CRISPR-Cas systems present in hundreds of bacterial
species.21,34-36 In S. pyogenes, tracrRNA is involved in the
virulence fitness of the pathogen by interfering with the
horizontal transfer of temperate phages encoding patho-
genicity factors. tracrRNA is critical in both the RNA
maturation step of the immune pathway and the inter-
ference with invading target phage DNA. tracrRNA
forms duplex RNAs with the precursor and processed
forms of crRNA. Processed tracrRNA duplexed with
mature crRNA forms the dual-tracrRNA:crRNA that
guides the Cas9 endonuclease to cleave site-specifically
the target DNA.37 The dual-tracrRNA:crRNA was sim-
plified into a single-guide RNA to form with Cas9 the
CRISPR-Cas9 complex that has now been widely har-
nessed for genome editing purposes in a large variety of
cells and organisms.21,34,37–41
In Gram-negative bacteria, sRNA/mRNA interactions
are often stabilized by the RNA chaperone Hfq.42 As
many other low-GC Gram-positive bacteria, S. pyogenes
does not encode an Hfq homolog.43 However, strepto-
coccal sRNAs may be assisted by proteins substituting
for Hfq, like RNA-binding proteins with chaperone, heli-
case or other RNA-related activities. The activity of regu-
latory RNAs in bacteria can also be controlled by
ribonucleases (RNases) such as RNase III, RNase E or
RNase Y. RNases have critical roles in the stabilization,
degradation or maturation of target mRNAs of sRNAs
(reviewed in refs.44,45). The highly conserved RNase III is
an endoribonuclease capable of cleaving double stranded
RNA (dsRNA). One of its main functions is processing
of the precursor rRNA (pre-rRNA).46 RNase III also
cleaves sRNA/mRNA and asRNA/mRNA duplexes.47,48
In Gram-negative bacteria, RNase E is involved in the
turnover of sRNA/mRNA duplexes in complex with
Hfq.49 Although streptococci do not encode RNase E,
they encode an endoribonuclease having similar cleavage
specificity, RNase Y. RNase Y is involved in mRNA and
sRNA decay, and riboswitch turnover.50,51 Both RNase
III and RNase Y were shown to affect virulence gene
expression in bacteria.21,52-54
In this study, we present an analysis of high-through-
put sRNA sequencing in the S. pyogenes SF370 clinical
isolate. We identified novel putative regulatory sRNAs
and demonstrate for the first time expression of asRNAs


























in this pathogen. The expression of selected asRNAs and
novel sRNA candidates was experimentally validated by
Northern blot analysis, revealing growth-phase depen-
dent expression of some of the sRNAs investigated. The
processing patterns of the asRNAs and sRNAs in RNase
III and RNase Y deletion mutants were also investigated.
Results
sRNA sequencing reveals asRNAs and sRNAs in
S. pyogenes
To identify novel sRNAs expressed in S. pyogenes SF370,
we constructed cDNA libraries from total RNA (depleted
from rRNAs) prepared from mid logarithmic phase cul-
tures using the ScriptMinerTM Small RNA-Seq kit. The
RNAs were treated with Tobacco Acid Pyrophosphatase
(TAP) to incorporate both processed and primary tran-
scripts in the cDNA libraries. The libraries were sub-
jected to  Illumina 100 bp single end sequencing. This
method is designed for sequencing of small transcripts
and strand-specific mapping. Since long transcripts are
not sequenced using this protocol, the retrieved reads in
this study can represent either single sRNAs or processed
parts of longer RNAs.
A total of 302 600 reads were mapped to the reference
genome and the number of reads starting (5’ start) and
ending (3’ end) at each single nucleotide position were
calculated. The maximal length of the mapped reads was
85 nt with the 3’ ends of longer RNAs that could not be
identified with certainty. We performed both a visual
and a bioinformatics screening for novel sRNAs. For the
bioinformatics screening, the reads were analyzed to
identify potential 5’ ends of RNAs. By screening for 5’
ends with at least 10 reads located at a specific position
(see Materials and Methods for more details), we identi-
fied 560 potential sRNA starts on the chromosome.
sRNAs were annotated either as located in coding
sequences (CDSs), antisense to CDSs, located in IGRs, as
part of 5’ untranslated regions (UTRs) (upstream) if they
were located less than 50 nt upstream of an annotated
gene, or as part of 3’ UTRs (downstream) if they were
located less than 50 nt downstream of an annotated
gene. 406 start sites were located in intergenic regions
(137), 5’ UTRs (220) and 3’ UTRs (49), which is 4.9 times
more than expected if the locations were randomly dis-
tributed over the chromosome. In contrast, 129 locations
were located in CDSs, which is 1.8 times less than
expected if the locations were randomly distributed over
the chromosome. We also identified 22 putative sRNA
starts located antisense to CDSs.
We annotated putative promoters and Rho-indepen-
dent terminators for the sRNAs identified by
bioinformatic screening (Table S1). 76.8% of the start
locations of the identified intergenic RNAs were associ-
ated with a predicted promoter element located just
upstream of the sRNA. This frequency is statistically sig-
nificantly higher (p-value <2.2 e-16, Kolmogorov-Smir-
nov test) than the frequency of predicted promoter
elements found when the location is randomly chosen
on the chromosome (0.5%). 86.8% of predicted sRNAs
part of 5’ UTRs were associated with a predicted pro-
moter element. Furthermore, 21.1% of all sRNAs had a
predicted terminator 300 nt downstream of their start
location, which is significantly more (p-value <2.2 e-16,
Kolmogorov-Smirnov test) than the 4.8% of predicted
transcriptional terminators found when the location is
randomly chosen on the chromosome. sRNAs found in
the 3’ UTRs had the highest percentage (44.9%) of pre-
dicted terminators (Fig. S1).
In the visual inspection screen for sRNAs, we selected
transcripts encoded within IGRs and antisense to anno-
tated transcripts. We identified a total of 197 putative
regulatory RNAs including 28 sRNAs predicted to be
encoded directly opposite to a transcript, possibly corre-
sponding to asRNAs. 141 sRNAs were found in both
visual and bioinformatics screenings of the sRNA
sequencing data, of which 14 were annotated as asRNAs.
Table S2 gives a summary of the various characteristics
of the reads for the visually screened putative sRNAs
including size, coordinates, coverage, direction of tran-
scription, predicted location and the identity of genes
located upstream and downstream of the sRNA loci. 97
sRNAs are predicted to be part of 5’ or 3’ UTRs. These
sRNAs could be cis-acting RNAs regulating the expres-
sion of the associated genes. 58 sRNAs were encoded
within IGRs and could function as trans-acting sRNAs.
We compared our list of predicted sRNAs identified by
visual screening with the lists of previously published
sRNAs identified in high-throughput in silico and micro-
array analyses of S. pyogenes clinical isolates (Table S2).
105 sRNAs were previously identified, from which only
16 were confirmed experimentally by Northern blot
analysis14-16,18-21 and 92 are novel sRNAs. In the visual
screening, we detected a total of 21 sRNAs encoded
within the 4 different prophages regions (370.1 – 370.4)
present in strain SF370 (Table S2). These sRNAs could
have regulatory functions in the biology of the prophages
or in the adaptation of S. pyogenes to its environment.
sRNAs with predicted functions
To validate the quality of our screening methods, we
used the Rfam database to retrieve S. pyogenes sRNAs
homologous to known sRNAs.55 We annotated 35



























functional sRNAs, ribosomal protein leaders, T-boxes
and putative riboswitches (Table S2).
The expression of the 4.5S RNA signal recognition
particle (SRP) (Spy_sRNA190336), tmRNA
(Spy_sRNA1065030), RNA component of RNase P
(Spy_sRNA1365555) and 6S RNA (Spy_sRNA1663522)
were validated by Northern blot analysis from S. pyo-
genes cultures grown at different growth phases (Fig. S2).
These sRNAs appeared to be constitutively expressed
during bacterial growth with a slight decrease of tmRNA
and RNase P RNA expression at the late stationary phase
of growth. As previously described, 6S RNA accumulates
during the stationary phase.56 Ribosomal protein leader
L19, L20, L21, L10 and L13 homologues and thrS, pheST,
alaS, valS, glyQS, serS and trsA T-boxes were also identi-
fied (Table S2). Northern blot analysis shows that expres-
sion of the tsrA T-box is considerably reduced from late
logarithmic through stationary phase of growth (Fig. S2).
We also performed Northern blot analysis of the purine
and glycine riboswitches, the yybP-ykoY element, the
metK2 riboswitch, PyrR1 and PyrR2, the asd element
and the TPP and FMN riboswitches (Table S1 and Fig.
S2). We show that the expression of these sRNAs under-
goes reduction starting early stationary phase of growth
(Fig. S2).
Regulatory elements regulated by RNases
Regulatory elements including Lacto-rpoB
(Spy_sRNA93359) and 23S-methyl (Spy_sRNA318404)
were detected in our screen (Table S2), and we propose
below that the expression of these elements is regulated
by RNase III in S. pyogenes.
The Lacto-rpoB motif was first identified by bioinfor-
matics analysis in Lactobacillales, always in the 5’ UTR
of the rpoB encoding an RNA polymerase subunit, and
was suggested to participate in the regulation of rpoB
expression.57 In strain SF370, Lacto-rpoB is located
between, and in the same orientation as, pbp1b and rpoB
and we predicted a putative promoter and a terminator
for this element (Fig. 1). We observed several transcript
forms of Lacto-rpoB by Northern blot analysis. We visu-
alize 2 long transcripts, and an additional small tran-
script (<42 nt) present in the wild type and Drny
(RNase Y deletion) strains but absent in the Drnc (RNase
III deletion) mutant (Fig. 1). The small processed tran-
script (<42 nt) could correspond to the RNase III
cleavage product of the long primary transcript of the
Lacto-rpoB element. We predicted the structure of the
Lacto-rpoB motif using RNAfold webserver58,59 and
observed that this RNA forms a well-structured RNA
with dsRNA regions (Fig. 1). Internal 5’ and 3’ ends
obtained in sRNA sequencing data were positioned on
the structure and we observed that these ends could
correspond to the 2 nt 3’ overhang characteristic of
RNase III cleavage (Fig. 1). RNase III cleavage of Lacto-
rpoB, based on structure prediction and sRNA sequenc-
ing data, would lead to the formation of a 29 nt tran-
script, corresponding to the <42 nt transcript detected
by Northern blot analysis.
Similarly to the Lacto-rpoB element, the 23S-methyl
motif is found upstream of the 23S rRNA methyltrans-
ferase in Lactobacillales and might regulate its expres-
sion.60 This RNA interacting enzyme could use the 23S-
methyl motif to autoregulate its expression, comparable
to the autoregulation of ribosomal protein genes.60 We
observed 2 transcripts of <200 nt and »70 nt by North-
ern blot. In the Drnc mutant strain, the <200 nt tran-
script is accumulating while the »70 nt of the transcript
is absent (Fig. 1). We propose that the <200 nt (102 nt
in sRNA sequencing) corresponds to a primary tran-
script while the »70 nt form corresponds to a processed
transcript that could be generated by RNase III-mediated
cleavage. The structure of the 23S-methyl motif was pre-
dicted using the RNAfold webserver58,59 and showed
that this RNA contains 2 long hairpins as previously
described.60 The ending of the second hairpin with a
stretch of uridines may indicate a Rho-independent tran-
scription terminator that could be involved in a tran-
scription regulation mechanism.60 The internal 5’ and 3’
ends obtained in sRNA sequencing data are located
within the first hairpin with a 2 nt 3’ overhang character-
istic of RNase III. A processed transcript of 66 nt results
from this cleavage, which is in accordance with the
»70 nt form observed by Northern blot analysis.
CiaR regulated sRNAs (csRNAs)
We detected 2 sRNAs, Spy_sRNA195261 and
Spy_sRNA1721621, corresponding to cia-dependent
sRNAs (csRNAs), csRNA15 and csRNA25 from the
S. pyogenes clinical isolate MGAS31532 (Fig. S3). These
sRNAs contain the TTTAAG-N5-TTTAAG consensus
binding sequence of CiaR in their promoter region (note
that for Spy_sRNA1721621, the first T is mutated and
replaced by a C). The two sRNAs also contain the puta-
tive anti-RBS and anti-start codon sequences, previously
described. We performed in vitro electrophoretic mobil-
ity shift assays of the Spy_sRNA195261 and
Spy_sRNA1721621 promoter regions with purified CiaR
(using a DNA template without the consensus binding
sequence as a negative control). Other potential binding
sequences containing various degrees of degenerated
consensus sequences recognized by CiaR were selected as
controls for the binding specificity (Fig. S3). We show
that CiaR binds to all promoters albeit with different
affinities. Higher binding affinity was observed for


























promoters with a sequence having a higher degree of
similarity to the consensus sequence, and mutations
within the consensus motif decreased the affinity of CiaR
to the DNA. We created an in-frame ciaR deletion
mutant and show in vivo by Northern blot analysis (Fig.
S3) that the expression of the 2 csRNAs,



























Spy_sRNA195261 and Spy_sRNA1721621, is down-reg-
ulated in the absence of CiaR in S. pyogenes, as described
in S. pneumoniae.32 A csRNA Spy_sRNA195261-defi-
cient mutant was constructed in S. pyogenes SF370. A
complete proteomic analysis of the mutant did not show
any variation of protein expression after false positive
reduction compared to the wild type strain in the culture
conditions tested (data not shown).
Novel sRNAs in S. pyogenes
We validated the expression of 15 novel sRNA candi-
dates by Northern blot analysis, from 31 sRNAs that
were analyzed (Table 1, Table S2, Fig. S4). Only three
sRNAs showed a constant expression during growth and
6 sRNAs had their expression reduced during early sta-
tionary growth phase compared to early- and mid-loga-
rithmic growth phases. Some of the sRNAs were
detected as several transcript forms of different sizes,
which suggests, as mentioned previously, that a large
number of identified sRNAs could be processed forms
originating from longer transcripts.
For a detailed analysis, we selected 4 distinct sRNAs as
examples, Spy_sRNA779816, Spy_sRNA1186876,
Spy_sRNA1212757 and Spy_sRNA1786666, that have
both a predicted promoter element and a predicted ter-
minator, and represent different lengths and regions (i.e
both prophage and non-prophage regions) (Fig. 2, Fig.
S5). Their expression was confirmed by Northern blot
analysis using total RNA extracted from S. pyogenes
SF370 cultured at different growth phases (early logarith-
mic, mid logarithmic and early stationary phases), and
their secondary structures were predicted with RNA-
fold58,59 (Fig. 2, Fig. S5).
Spy_sRNA779816 is encoded between the int3 and
Spy_0938 genes of prophage 370.3. Two main forms of
the sRNA, with sizes approximately corresponding to
those inferred from RNAseq data, were detected by
Northern blot. We propose that the longer form (89 nt
in sRNA sequencing data) is a primary transcript, which
is processed into the smaller form at a position identified
in the sRNA sequencing data (Fig. 2A). This sRNA is
also present in Manfredo and NZ131 S. pyogenes strains
and Streptococcus parauberis KCTC 11537.
Spy_sRNA1186876 is encoded between SPy_1432
(pyrD dihydroorotate dehydrogenase 1A) and SPy_1434
(heavy metal-transporting ATPase). We detected 2 forms
of this sRNA of »500 nt and >200 nt in size by Northern
blot analysis. We could not identify any reads or pre-
dominant 5’ ends in our sequencing data that would cor-
respond to the longer detected transcript, and thus we
are unable to comment on its origin. Since the size of the
shorter transcript perfectly corresponds to the size of
transcript starting from the predicted promoter to the
predicted terminator of the sRNA (143 nt), we hypothe-
size that the shorter RNA is a primary transcript and
does not originate from the longer RNA. This sRNA is
also present in Manfredo and NZ131 S. pyogenes strains
and in Streptococcus dysgalactiae subsp. equisimilis
GGS_124.
Spy_sRNA1212757 is encoded between 2 hypothetical
genes in the vicinity of prophage 370.2 and we observed
by Northern blot analysis a small transcript of 42 nt cor-
responding to the size visualized in the sRNA sequencing
data (Fig. 2, Fig. S4, Fig. S5). This sRNA is unusually
short, but a defined Northern blot signal, convincing
promoter and terminator predictions, together with the
unstructured 5’ end that should be prone to degradation
indicates that this transcript is functional. This RNA is
also present with 100% conservation in the S. pyogenes
clinical isolates, Manfredo, A20, and HSC5.
The last example, Spy_sRNA1786666, is encoded at
one extremity of the 370.4 prophage region between
SPy_2147 and SPy_2148 (mutS: DNA mismatch repair
protein MutS). In accordance with the sRNA sequencing
data, we observed a single transcript of >82 nt by North-
ern blot analysis (Fig. 2, Fig. S4, Fig. S5). This RNA is
also present with 100% conservation in Manfredo and
MGAS10270 S. pyogenes strains and in S. dysgalactiae
subsp. equisimilis 167.
Novel putative sRNAs regulated by RNases
Northern blot analysis shows that the expression of 2 novel
sRNAs is regulated by RNase III (Spy_sRNA1222613 and
Spy_sRNA1571135) and the expression of 4 novel sRNAs
Figure 1. (see previous page) Lacto-rpoB and 23S methyl RNA elements are regulated by RNase III in S. pyogenes. A. Northern blot
analysis (polyacrylamide gel electrophoresis) of Lacto-rpoB and 23S-methyl RNA expression in WT (SF370), DRNase III (Drnc) and DRNase
Y (Drny) strains grown to early logarithmic (EL), mid logarithmic (ML) and early stationary (ES) phases. 5S rRNA is used as loading con-
trol. B. Expression profiles of Lacto-rpoB and the 23S-methyl motif with surrounding genes captured using the Integrative Genomics
Viewer (IGV) software. The sequence coverage was calculated using BEDTools-Version-2.15.0 and the scale is given in number of reads
per million. The distribution of reads starting (5’) and ending (3’) at each nucleotide position is represented in blue and orange, respec-
tively. The position of the oligonucleotide probes (OLEC) used in Northern blot analysis is indicated. C. Prediction of RNA secondary
structure using RNAfold (rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). The arrows represent putative cleavages by RNase III (nucleotides
determined by analyzing the 5’ and 3’ ends of the sRNAs in sRNA sequencing data).


























is regulated by RNase Y (Spy_sRNA1222613,
Spy_sRNA1300419, Spy_sRNA1774740 and
Spy_sRNA1775122) (Fig. 3 and Fig. S4).
Spy_sRNA1222613 is encoded within the prophage
370.2 between the int2 and hlpA genes and overlaps
with the 3’ UTR of hlpA (histone-like DNA-binding
protein). HlpA is described to bind to lipoteichoic
acid and epithelial cells and was shown to play a role
in the virulence of S. pyogenes.61 In the wild type
strain, Northern blot analysis shows that
Spy_sRNA1222613 is part of a long transcript
(>800 nt) expressed at all phases of growth. In addi-
tion, 2 smaller transcripts (between 24 and 48 nt) are
visible, one small transcript (»30 nt) during the early
logarithmic growth phase and the other transcript
(»48 nt) during the early stationary growth phase.
However, no transcript was detected during the mid
logarithmic phase of growth (Fig. 3A and Fig. S4).
The smallest transcript (»30 nt) is absent in the Drnc
strain, suggesting that this short form originates from
the 3’ UTR hlpA mRNA by processing by RNase III.
The »48 nt form is absent in the Drny strain, proba-
bly resulting from RNase Y processing of the 3’ UTR
hlpA mRNA (Fig. 3A). The 3’ UTR of the hlpA
mRNA seems to be tightly regulated during growth in
an RNase III and RNase Y dependent manner. It is
still to be determined whether the 2 small transcripts
are products originating through processing via an
interaction with a target or whether they originate
from hlpA growth dependent autoregulation.
Spy_sRNA1300419 is encoded within the 3’ UTR of
aroB (3-dehydroquinate synthase) and its expression was
detected by Northern blot only during early stationary
phase of growth (Fig. 3B). In the Drny mutant, this
»50 nt transcript is absent, indicating that
Spy_sRNA1300419 probably corresponds to a processed
form of 3’ UTR aroB mRNA generated by this endoribo-
nuclease (Fig. 3B).
Spy_sRNA1571135 is encoded in the 3’ UTR of rpoE
(DNA-directed RNA polymerase subunit delta). Its
expression is comparable between wild type, Drnc and
Drny strains, however in the Drnc mutant, a longer tran-
script is also present (Fig. 3C). We hypothesize that
expression of this transcript is regulated by RNase III in
the wild type and Drny strains (Fig. 3C).
Spy_sRNA1774740 and Spy_sRNA1775122 are
encoded next to each other on opposite strands between
int4 (integrase) and SPy_2125 (a repressor protein) in
the genome of prophage 370.4. Northern blot analysis
shows 3 different transcripts for Spy_sRNA1774740 and
2 forms for Spy_sRNA1775122 (Fig. 3D). The expression
of the longest transcript form (»150 nt) of
Spy_sRNA1774740 is upregulated in the absence of
RNase Y. The two smaller transcripts are only visible
during the early stationary phase of growth in the wild
type and Drnc but are absent in the Drny mutant
(Fig. 3D). The smallest transcript form of
Spy_sRNA1775122 is also present during the early sta-
tionary phase of growth and is absent in the Drny
mutant. The small transcript forms of both sRNAs prob-
ably result from RNase Y cleavage.
Antisense RNAs
Remarkably, our analysis of the sRNA sequencing
data allowed identification of novel sRNAs (Table S2,
Table 2) located antisense to annotated transcripts,
thus being putative asRNAs. We divided the asRNAs
into 3 categories based on their location (Table 2),
namely directly antisense to the CDS, or antisense to
the 5’ or 3’ UTRs of transcripts. A total of 36 putative
asRNAs were retrieved, 28 by visual screening (Table
Table 1. List of selected sRNAs. The sRNA identifier, location in prophages, strand, surrounding genes (immediately located upstream
and downstream of the sRNAs) and coverage (number of cDNA reads calculated using SAMtools) are indicated.
Name Phage Strand Upstream Downstream Coverage
Spy_sRNA542268 370.1 ¡ SPy_0671 hypothetical protein SPy_0672 hypothetical protein 8
Spy_sRNA544833 370.1 C SPy_0677 phage associated protein SPy_0678 phage associated protein 33
Spy_sRNA694150 C SPy_0841 RNA binding protein SPy_0843 hypothetical protein 23
Spy_sRNA779816 370.3 C SPy_0937 int3: Integrase SPy_0938 hypothetical protein 405
Spy_sRNA1110925 ¡ SPy_1340 major facilitator superfamily permease SPy_1343 hypothetical protein 82
Spy_sRNA1186876 ¡ SPy_1432 pyrD: dihydroorotate dehydrogenase 1A SPy_1434 heavy metal-transporting ATPase 23
Spy_sRNA1212757 370.2 C SPy_1469 hypothetical protein SPy_1470 hypothetical protein 37
Spy_sRNA1222613 370.2 ¡ SPy_1488 int2: integrase SPy_1489 hlpA: histone-like DNA binding protein 116
Spy_sRNA1260092 ¡ SPy_1531 dpr: Dps-like peroxide resistance protein SPy_1532 leader peptidase family protein 219
Spy_sRNA1300419 C SPy_1577 aroB: 3-dehydroquinate synthase SPy_1580 acetate kinase 90
Spy_sRNA1571135 ¡ SPy_1894 pyrG: CTP synthetase SPy_1895 rpoE: DNA-directed RNA polymerase subunit delta 26
Spy_sRNA1755445 ¡ SPy_2099 trehalose operon transcriptional repressor SPy_2102 transcriptional regulator MarR family 2176
Spy_sRNA1774740 370.4 C SPy_2122 int4: integrase SPy_2125 repressor protein 46
Spy_sRNA1775122 370.4 ¡ SPy_2122 int4: integrase SPy_2125 repressor protein 102



























S2) and 22 by the bioinformatics screening (Table
S1), with 14 found in both screenings. We selected 21
transcripts from the visual screening for further
analysis (Table S2). The expression of 10 RNAs anti-
sense to UTRs and 5 RNAs antisense to CDSs was
validated at different growth phases (early
Figure 2. Expression profiles of selected sRNAs. For each sRNA, the locus is depicted with the sRNA in green and the surrounding genes
in gray. The prophage regions are indicated in purple. The RNA sequencing expression profiles are captured using the Integrative Geno-
mics Viewer (IGV) software. The sequence coverage was calculated using BEDTools-Version-2.15.0 and the scale is given in number of
reads per million. The putative promoters and terminators are indicated in black. Northern blot analysis (PAGE) were performed in WT
(SF370) strains grown to early logarithmic (EL), mid logarithmic (ML) and early stationary (ES) phases. The position of the oligonucleotide
probes (OLEC) used in Northern blot analysis is indicated. The 5S rRNA is used as a loading control. Folding for the sRNAs was predicted
using RNAfold (rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). The arrow in (A) represent a putative cleavage site in the RNA. See also Figures
S4 and S5 for additional information regarding sRNA sequencing (expression profiles by Northern blot and RNA sequencing analyses,
sequence conservation).


























logarithmic, mid logarithmic and early stationary
phases) in the wild type, Drnc and Drny strains by
Northern blot analysis (Table 2, Fig. S6).
Most asRNAs seem to be constitutively expressed dur-
ing growth, with 3 asRNAs that were downregulated.
Several transcript forms were visualized for 7 asRNAs.
The asRNA sizes inferred from the Northern blot data
are sometimes higher than the ones retrieved from RNA
sequencing, which is an artifact of our sequencing
method directed toward detection of short transcripts.
For most of the asRNA candidates, it is likely that they
are products of processing or degradation of longer
RNAs. Interestingly, 9 asRNAs were expressed as short,
defined RNA species of up to 150 nt in length.
Four asRNAs harboring both a promoter and termi-
nator, with a defined size smaller than 150 nt as observed
by Northern blot analysis were selected as examples
(Fig. 4, Fig. S7). We hypothesize that these 4 asRNAs are
primary transcripts. The secondary structures of the
selected asRNAs was predicted using RNAfold58,59
(Fig. 4). Spy_sRNA392987 is located antisense to the 5’
UTR of the pseudogene SPy_0481 (transposase). The
sizes of this sRNA retrieved by sRNA sequencing and
Northern blot analysis are identical (61 nt) (Fig. 4).
Figure 3. Expression profiles of sRNAs regulated by RNases. Northern blot analysis of selected sRNAs showing a variation in expression
or processing between WT (SF370), DRNase III (Drnc) and DRNase Y (Drny) strains grown to early logarithmic (EL), mid logarithmic (ML)
and early stationary (ES) phases. 5S rRNA is used as a loading control. For each sRNA, the locus is depicted with the sRNA in green and
the surrounding genes in gray. The prophage regions are indicated in purple. For a detailed set of Northern blots and sRNA sequencing



























Spy_sRNA392987 is present at one or 2 loci in numerous
strains of S. pyogenes, and in Streptococcus agalactiae and
S. dysgalactiae (Fig. S8). Spy_sRNA531081,
Spy_sRNA800369 and Spy_sRNA1221370 are encoded
antisense to the 3’ UTRs of phage hypothetical genes
(respectively SPy_0656, SPy_0978 and SPy_1487).
Spy_sRNA531081 is conserved in various Streptococcus.
pyogenes strains, and in S. agalactiae and S. equi.
Spy_sRNA800369 is only found in S. pyogenes Alab49.
Spy_sRNA1221370 is present in various S. pyogenes strains
and in S. equi and S. agalactiae (Fig. S8).
asRNAs regulated by RNases
We observed by Northern blot analysis that 2 asRNAs,
Spy_sRNA477741 and Spy_sRNA480696, are differently
regulated in the RNase deletion mutants (Fig. 5).
Spy_sRNA477741 is located antisense to the 3’ UTR
of SPy_0593 hypothetical protein. Two long transcripts
of >400 nt are detected in the wild type strain (Fig. 5).
Both transcripts are absent in the Drnc strain, and only
the longer transcript is present in the Drny strain
(Fig. 5), suggesting that the longest Spy_sRNA477741
transcript originates from RNase III cleavage and the
smallest transcript is a product of RNase Y cleavage.
Spy_sRNA480696 is encoded between SPy_0596
(hypothetical protein) and SPy_0598 (phosphoglycerate
mutase). The 3’ UTRs of both SPy_0596 and SPy_0598
are overlapping. Spy_sRNA480696 is antisense to
SPy_0596 and Northern blot analysis shows a »66 nt
transcript in the wild type and Drny strains. In the Drnc
deletion mutant, the transcript is longer, suggesting that
the »66 nt form may be produced by RNase III cleavage
(Fig. 5).
The defined sizes and convincing promoter and ter-
minator predictions of these described asRNAs indicate
that at least a subset of the new identified RNAs consti-
tute products of specific and not pervasive transcription.
The differential expression patterns and detected proc-
essings by RNases further suggest that these asRNAs
could be functional, regulatory sRNA species. The bio-
logical function and exact nature of longer asRNA tran-
scripts remain to be determined.
Discussion
In this study, we aimed to identify novel sRNAs
expressed in S. pyogenes. An analysis of sRNA sequenc-
ing in strain SF370 cultured to mid logarithmic phase
revealed a total of 197 putative sRNAs from which 92 are
new, located in 5’ UTRs, 3’ UTRs, IGRs or antisense to
transcripts.
The sRNA screening was validated by the retrieving of
a few regulatory RNAs that were already identified and
studied in S. pyogenes, namely FasX RNA
(Spy_sRNA213738), Pel RNA (Spy_sRNA598538) and
tracrRNA (Spy_sRNA854545). However, we could not
detect the expression of RivX RNA in the sRNA sequenc-
ing data of SF370. RivX could either be specific to strain
JRS4 (M6 serotype) or expressed only in specific condi-
tions in strain SF370.21,37 The quality of our screening
method was also validated by the retrieval of homologues
of known functional sRNAs such as the 4.5S RNA,
Table 2. List of selected asRNAs. The asRNA identifier, location in prophages, strand, putative target genes and coverage (number of
cDNA reads calculated using SAMtools) are indicated. Classification: asRNAs from 3 different families were retrieved from the sRNA
sequencing data. asRNAs are depicted in red and putative target mRNAs are indicated in purple. 5’ UTR and 3’ UTR correspond to
asRNAs that are complementary to the 5’ and 3’ UTRs of their putative target mRNAs, respectively. CDS corresponds to asRNAs that are
complementary to the coding sequences of their putative target mRNAs. UTR: untranslated region; CDS: coding sequence.
Classification Name Phage Strand mRNA putative target gene Coverage
Spy_sRNA392987 C SPy_0481: transposase 220
Spy_sRNA480642 C SPy_0598: phosphoglycerate mutase
108
Spy_sRNA480696 ¡ SPy_0596: hypothetical protein
71Spy_sRNA477741 ¡ SPy_0593: hypothetical protein
100Spy_sRNA531081 370.1 C SPy_0656: hypothetical protein
140Spy_sRNA532788 370.1 ¡ SPy_0658: hypothetical protein
68Spy_sRNA800369 370.3 ¡ SPy_0978: hypothetical protein
878Spy_sRNA1221370 370.2 ¡ SPy_1487: hypothetical protein
136Spy_sRNA1718031 ¡ SPy_2063: hypothetical protein
46Spy_sRNA1778807 ¡ SPy_2129: hypothetical protein
334
Spy_sRNA728180 C SPy_0880: mvaS.1, 3-hydroxy-3-
0methylglutaryl-coenzyme A
21
Spy_sRNA924338 ¡ SPy_1128: eutD phosphotransacetylase 29
Spy_sRNA1032107 C SPy_1251: tRNA pseudouridine synthase B 37
Spy_sRNA1063616 ¡ SPy_1287: ABC transporter permease 155
Spy_sRNA1167444 C SPy_1408: comEC, competence protein 68


























tmRNA, the RNA from RNase P, the 6S RNA and the 2
pRNAs (RNA products) that are transcribed from both
strands of the 6S RNA during the sequestration of the
RNA polymerase.62 Ribosomal protein leaders, T-boxes
and known predicted riboswitches (purine, glycine,
yybP-ykoY element, metK2, Pyr1 and Pyr2, asd, TPP
and FMN) were also retrieved in our data.
We also found CiaR regulated csRNAs, as previ-
ously described in ref.32. CiaR is the response regula-
tor of the 2-component system CiaRH. CiaR binds to
Figure 4. Expression profiles of selected asRNAs. For each asRNA, the locus is depicted with the asRNA in green and the antisense
genes in gray. The prophage regions are indicated in purple. The RNA sequencing expression profiles are captured using the Integrative
Genomics Viewer (IGV) software. The sequence coverage was calculated using BEDTools-Version-2.15.0 and the scale is given in number
of reads per million. The putative promoters and terminators are indicated in black. Northern blot analysis (polyacrylamide gel electro-
phoresis) was performed in WT (SF370) strains grown to early logarithmic (EL), mid logarithmic (ML) and early stationary (ES) phases.
The position of the oligonucleotide probes (OLEC) used in Northern blot analysis is indicated below the sequence coverage. The 5S
rRNA is used as a loading control. Folding for the sRNAs was predicted using RNAfold (rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). See also



























the DNA sequence TTTAAG-N5-TTTAAG in pro-
moter regions and regulates the expression of the
associated downstream gene.32 CiaRH has regulatory
functions in various phenotypes like ß-lactam resis-
tance, autolysis, virulence and competence develop-
ment, however the molecular mechanisms involved
are still unknown.32 In S. pneumoniae, CiaR can bind
to the promoters of 5 small non-coding csRNAs.31 In
this bacterial species, the expression of 6 genes is
under the control of csRNA-mediated regulation,
including the comC mRNA, which encodes the pre-
cursor of CSP, defining a link between CiaR and
competence control.33 It has also been described that
all streptococcal genomes contain between 2 and 6
csRNA genes.32 All csRNAs are highly similar to one
another as they all contain a UCCUCC sequence
(putative anti-RBS) and a CCUC(N6)CAU sequence
(putative anti-start codon). In this study, we observe
that both Spy_sRNA195261 and Spy_sRNA1721621
show several transcript forms that are expressed from
the lag to the early stationary phase of growth (Fig.
S3). The Spy_sRNA1721621 expression also decreases
during the transition between logarithmic and station-
ary phases of growth. The expression of both sRNA
transcripts is reduced in a ciaR deficient mutant (Fig.
S3). The study of the proteome of the
Spy_sRNA195261 deletion mutant did not provide
any indication with regard to a putative function for
this RNA. Unlike S. pneumoniae, S. pyogenes is not
naturally transformable and the function of the
CiaRH homolog in this species remains still unclear.
For the first time, we show expression of asRNAs
in S. pyogenes. asRNAs are encoded on the DNA
strand opposite to their putative target, therefore
being perfectly complementary. Antisense transcripts
have been described opposite to transcripts encoding
transposases, potentially toxic proteins, transcription
regulators, metabolic enzymes, or transcription fac-
tors. asRNAs can overlap either with the 5’ UTRs, 3’
UTRs or CDSs of their target and interfere with
mRNA transcription, stability or translation at the
condition that both RNAs are expressed at the same
time in the same cell. Although the exact function of
most asRNAs still remain to be investigated,10 they
act mostly by reducing the expression of the sense
gene.63 Their function is often associated with RNase
activity.64 For example, in Staphylococcus aureus,
sense/antisense overlapping transcripts are processed
by RNase III, generating a collection of short RNA
fragments (20 nt on average).65,66 More than 300
asRNAs, forming a >40 nt complementary duplex
with their target that is recognized by RNase III, were
also identified in E. coli.48 asRNAs can also form
RNA duplexes with target mRNAs, resulting in inhi-
bition of target decay.64,67 Surprisingly, none of the
published screens of S. pyogenes sRNAs have reported
the expression of asRNAs, probably because of differ-
ences in the methods used (microarray analysis and
computational predictions).24 In general, technical dif-
ficulties to distinguish from which strand the RNAs
are expressed delayed the discovery of bacterial asR-
NAs compared to other trans-acting small RNAs.
However, insilico searches led to the identification of
63 asRNAs in S. agalactiae, from which 3 were vali-
dated by Northern blotting analysis.68 Two sRNAs
and one sRNA were shown to regulate their target
expression negatively and positively, respectively. In
the present study, we identified 28 putative asRNAs
encoded antisense to 5’ UTRs, 3’ UTRs or CDSs by
visual screening, from which 15 were validated by
Northern blot analysis. Although some asRNAs have
their own promoter and terminator, we show that
most of these small transcripts could originate from
longer transcripts (not detected in the sRNA sequenc-
ing data) (Fig. S6). A class of asRNAs that overlap
with the 5’ UTRs of transposase genes was described
in various bacteria and archaea. In Methanosarcina
Figure 5. Expression profiles of asRNAs regulated by RNases.
Northern blot analysis of selected asRNAs showing a variation in
expression or processing between WT (SF370), DRNase III (Drnc)
and DRNase Y (Drny) strains grown to early logarithmic (EL), mid
logarithmic (ML) and early stationary (ES) phases. 5S rRNA is used
as a loading control. For a detailed set of Northern blots and sRNA
sequencing expression patterns, refer to Figure S6.


























mazei, these asRNAs are differentially expressed in
response to nitrogen, and therefore transposon mobil-
ity could be regulated at the post-transcriptional level
in a nitrogen-dependent manner.69 In E. coli, asRNAs
were shown to regulate the translation of transposases
in Tn10 and Tn30 transposons70,71 and similar asR-
NAs were also found in Sulfolobus solfataricus.72 We
speculate that asRNA Spy_sRNA392987, which is also
located in the 5’ UTR of the transposase mRNA,
could have a similar role.
To characterize sRNAs further, we studied the expres-
sion of selected sRNAs in strains lacking the genes
encoding RNase III or RNase Y. These two endoribonu-
cleases are not essential in S. pyogenes, and they have
been shown to have critical roles in the regulation of
sRNA expression in other bacterial species. RNase III
plays a role in the degradation of mRNAs during transla-
tional silencing by sRNAs.46 RNase Y acts in the degra-
dation and processing of mRNAs and sRNAs, as well as
in the initiation of riboswitch turnover.51,52,73 We found
that expression of the Lacto-rpoB and the 23S methyl
putative regulatory elements is regulated by RNase III.
The expression of 2 additional sRNAs (Spy_sRNA1222613
and Spy_sRNA1571135) is also regulated by RNase III,
and the expression of 4 sRNAs (Spy_sRNA1222613,
Spy_sRNA1300419, Spy_sRNA1774740 and
Spy_sRNA1775122) is regulated by RNase Y. We also
show that RNase III regulates the expression of 2 asRNAs,
Spy_sRNA477741 and Spy_sRNA480696, and that RNase
Y regulates the expression of one asRNA,
Spy_sRNA477741. These regulations may suggest the
involvement of these sRNAs or asRNAs in the direct regu-
lation of target mRNA expression. In addition, the possible
processing and degradation of sRNAs from all classes (cis-
acting, putative trans-acting regulatory RNAs and
asRNAs) by either of these enzymes highlight the role of
sRNA regulation by processing in S. pyogenes.
Conclusion
To conclude, we identified asRNA candidates and new
putative regulatory RNAs in the human pathogen S. pyo-
genes during growth in axenic cultures using sRNA
sequencing. Our analysis increases the inventory of puta-
tive sRNAs with regulatory functions in this pathogen.
We established a link to the mechanism of action of
selected sRNAs and asRNAs by studying their transcrip-
tion in two RNase deletion mutants (RNase III and
RNase Y). Our observations that expression of these
RNAs is tightly regulated, by either growth phase or
RNases may predict that they have regulatory roles in S.
pyogenes. Future studies should aim to sRNA target iden-
tification and elucidation of specific mechanisms of
action in this pathogen. Despite the constant improve-
ment of target prediction methods, the challenge remains
to demonstrate the regulatory roles and molecular mech-
anisms of action of this increasing collection of sRNAs
and asRNAs.
Materials and methods
Bacterial strains and growth conditions
Table S3 describes the bacterial strains used in this study.
S. pyogenes M1 GAS SF370 (wild type, ATCC 700294)
and derivative deletion mutants were cultured at 37C
without agitation in a 5% CO2 atmosphere. Todd Hewitt
broth supplemented with 0.2% yeast extract and plates
containing tryptic soy agar supplemented with 3% sheep
blood were used as liquid and solid media, respectively.
When required, antibiotics were added to the medium at
the following final concentrations: erythromycin, 3 mg/
ml; kanamycin, 300 mg/ml. Bacterial growth was moni-
tored at regular time intervals at OD620nm with a micro-
plate reader using 200 ml of culture (EonTM, biotek®).
Bacterial transformation
When not stated otherwise, electrocompetent S. pyogenes
cells were prepared as ref.74 For the chromosomal dele-
tion of rny (encoding RNase Y), bacterial transformation
was performed as follows. Cells were grown overnight in
5 ml of THY medium containing 0.5 M sucrose and
80 mM L-Threonine. The overnight culture was diluted
1/100 in 500 ml of the same media and grown until mid
logarithmic phase. The culture was centrifuged and the
pellets were washed 3 times in 50 ml of ice cold 0.5 M
sucrose and resuspended in 2 ml of ice cold 0.5 M
sucrose. 100 ml of GAS electro-competent cells were
transformed with 1 mg DNA under electroporation con-
ditions of 1.8 kV, 25 mF and 400 V. The bacteria were
grown in 6 ml of THY immediately after transformation
and incubated for 2 hours at 37C, 5% CO2 before being
spread on the appropriate selection plates.
Chromosomal deletion of RNase III and RNase Y
The rnc (encoding RNase III) deletion mutant used in
this study was previously generated in S. pyogenes
SF370.21 The in-frame deletion of rny (encoding RNase
Y) in strain SF370 was performed as follows. Amplifica-
tion of DNA sequences located upstream and down-
stream of the rny coding sequence was performed using
Phusion® polymerase (Thermo Scientific) and primer
pairs OLEC1998/OLEC1999 and OLEC2000/OLEC2501,



























by the lox71 and lox66 sites75 was amplified using
OLEC1943 and OLEC1932. The three fragments
(upstream of the coding sequence, erythromycin resis-
tance cassette and downstream of the coding sequence)
were ligated together by PCR-mediated ligation using
OLEC1998 and OLEC2501. The linear fragment
obtained was purified and used in transformation experi-
ments using electrocompetent S. pyogenes SF370 as
described above. Following homologous recombination
at the level of upstream and downstream sequences of
the rny gene, erythromycin resistant cells were selected
and the gene replacement event was verified by PCR
analysis. Clones harboring the rny gene replaced with
the erythromycin resistance cassette were transformed
with pEC455, a plasmid encoding kanamycin resistance
and the Cre recombinase under the control of a constitu-
tive promoter to promote excision of the erythromycin
cassette through resolution at the lox sites. Clones resis-
tant to kanamycin and sensitive to erythromycin were
selected and cultured in THY without antibiotic to elimi-
nate pEC455. Clones sensitive to erythromycin and
kanamycin were further selected, and the replacement of
the rny gene with the resolved lox72 site was verified by
PCR and sequencing analyses.
Chromosomal deletion of ciaR
The in-frame deletion of the ciaR gene in S. pyogenes
SF370 was constructed as follows. Amplification of the
upstream and downstream sequences of the ciaR coding
sequence was performed using Phusion® polymerase
(Thermo Scientific) and primer pairs OLEC1350/
OLEC1351 and OLEC1352/OLEC1353, respectively. The
two fragments were ligated by PCR using OLEC1350
and OLEC1353. The PCR product was digested by
BamHI and EcoRI and cloned into pEC214 to generate
pEC277. The ciaR coding sequence overlaps the ciaH
coding sequence from the same operon. To avoid a mis-
translation of ciaH, a silent mutation of the stop codon
of ciaR (within the ciaH coding sequence) was created
without modifying the ciaH coding sequence. pEC277
was purified and introduced into S. pyogenes SF370.
Kanamycin-resistant and blue clones were selected on
TSA blood plates containing X-gal at 28C. A series of
temperature shifts at 37C (integration of pEC277), 28C
(excision of the plasmid) and 37C (elimination of the
plasmid) were performed. Kanamycin sensitive, white
clones with excised pEC277 were selected and the correct
deletion of ciaR in the mutant strains was verified by
PCR analysis. The deletion event was further confirmed
by Southern blot, Northern blot, sequencing and RT-
PCR analyses.
RNA extraction
Total RNA from S. pyogenes SF370 wild type, deletion
mutants and complemented strains was prepared using
TRIzol (Sigma-Aldrich)/chloroform extraction and iso-
propanol precipitation from samples collected at several
phases of growth (early logarithmic phase, EL; mid loga-
rithmic phase, ML, and early stationary phrase, ES).
RNA concentration and integrity were determined using
nanodrop and agarose gel electrophoresis.
Polyacrylamide northern blot analysis
Northern blot analysis was carried out as described in.36
Briefly, total RNA was separated on 10% polyacrylamide
gels (8 M urea) and transferred onto nylon membranes
(HybondTM NC, GE healthcare; Trans-Blot® SD semi-
dry transfer apparatus, Biorad; 1X TBE, 45 min, 20 V).
The crosslinking was performed using EDC (1-Ethyl-3-
(3-dimethylaminopropyl) carbodiimide hydrochloride)76
and prehybridization was done using Rapid-hyb buffer
(GE healthcare; 1 h at 42C). The T4-polynucleotide
kinase (Fermentas) was used to label 40 pmol of oligonu-
cleotide probes with 32P (0.75 MBq) according to the
manufacturer’s protocol. The probes were purified with
G-25 columns (GE Healthcare). Visualization of the
radioactive signal was done using FLA-9000 (Fujifilm),
including 5S rRNA as loading control. The approximate
sizes of RNA fragments were estimated according to the
FX174 DNA/HinfI Marker (Fermentas).
Identification of putative CiaR binding sites
Putative CiaR binding sites in the S. pyogenes SF370
genome were determined by search for the consensus
binding motif TTTAAG-N5-TTTAAG
31 using the Vec-
torNTI software. Up to 2 mismatches to the consensus
sequence were allowed and only sequences located
within the putative promoters of target genes and sRNAs
were selected for further analysis.
CiaR purification
The ciaR gene was amplified from S. pyogenes SF370
chromosomal DNA with Phusion polymerase (Finn-
zymes) using primers OLEC1471 and OLEC1472 and
cloned into the pET21 (C-terminal His-Tag) overexpres-
sion vector using NdeI and XhoI. Following verification
by sequencing analyses, the recombinant plasmid was
transformed into E. coli BL21 overexpression strain using
a heat-shock transformation protocol. Bacteria were
grown at 37C with shaking in LB medium containing
100 mg/ml ampicillin to an OD600nm of 0.8. After


























induction with 0.5 mM IPTG, bacteria were further
grown for 4 hours at 37C with shaking. Cells were col-
lected by centrifugation at 4000 rpm for 10 min at 4C
and resuspended in lysis buffer (50 mM NaH2PO4,
300 mM NaCl pH 8.0) supplemented with EDTA-free
protease inhibitor cocktail (Roche). After 30 min incuba-
tion on ice, cells were lysed by sonication for 2£2 min.
The lysate was cleaned from cell debris by a 10 min cen-
trifugation at 4C and 15000 £ g. The supernatant was
incubated for an hour at 4C with Ni-NTA agarose beads
(Qiagen) previously washed with lysis buffer. The resin
was loaded on the gravity column and washed with lysis
buffer supplemented with increasing amounts of imidaz-
ole (twice 20 mM and once 40 mM). The protein was
eluted with lysis buffer containing 250 mM imidazole
and checked for purity by SDS-PAGE analysis. The pro-
tein concentration was determined using the Bradford
reagent (BioRad).
CiaR electrophoretic mobility shift assays
Putative promoter fragments (»125 bp) encompassing
the determined CiaR binding motif (see above) and the
coding sequence of Spy_sRNA195261 (negative control)
were amplified from S. pyogenes SF370 chromosomal
DNA by PCR using primers listed in Table S3. Phusion
polymerase (Finnzymes) was used and the amplified
fragments were purified using a PCR purification kit
(Qiagen). 40 ng (0.5 pmol) of DNA fragments were incu-
bated in 15 ml reactions in band shift buffer (20 mM
HEPES, 10 mM (NH4)2SO4, 1 mM DTT, 30 mM KCl,
10 mM MgCl2, pH 7.9) as previously described
31 with
varying amounts of purified His-tagged CiaR. Reactions
were incubated at room temperature for 30 min and
loaded on native 8% polyacrylamide gel in 1£ TGE
(50 mM Tris, 400 mM glycine, 1.73 mM EDTA). Bands
were visualized with a 3 min EtBr staining. PCR frag-
ment without the CiaR binding motif served as a DNA
negative control.
cDNA library preparation, sequencing analysis and
criteria for putative sRNA selection
cDNA library preparation and analysis were carried out
essentially as described previously.34 Briefly, S. pyogenes
SF370 was cultured until mid logarithmic (ML) growth
phase. Total RNA was extracted with TRIzol (Sigma-
Aldrich)/chloroform and treated with TURBOTM DNase
(Ambion) and Ribo-ZeroTM rRNA Removal Kit® for
Gram-positive bacteria (Epicentre). ScriptMinerTM Small
RNA-Seq Library Preparation Kit (Multiplex, Illumina®
compatible, Epicentre) was used to prepare the library
using Tobacco Acid Pyrophosphatase (TAP) (Epicentre).
cDNAs were sequenced at the Next Generation Sequenc-
ing (CSF NGS Unit; http://csf.ac.at/)) facility of the
Vienna Biocenter, Vienna, Austria (Illumina single end
sequencing). Cutadapt (version 1.0)77 was used to
remove adapter sequences. For reads where an adapter
sequence was identified, only reads longer than 15 nt
were kept for further analysis. For reads were no adapter
sequence was identified, the last 15 nt were removed to
increase the overall quality of the reads. The remaining
reads were aligned to the S. pyogenes genome (GenBank:
NC_002737) using Bowtie (version 1.1.0) with 2 mis-
matches allowed (-v 2). An in-house script was used to
count the total coverage, the 5’ and 3’ ends of all mapped
reads at each nucleotide position, for each DNA strand.
The reads were visualized using the Integrative Geno-
mics Viewer (IGV).78 For the analysis of sRNA sequenc-
ing data using bioinformatics, putative sRNA candidates
were selected based on the following criteria: location in
the IGRs, total read counts above 10 and a distinct 5’
end. A distinct 5’ end was defined by 2 criteria: 50% of
all the reads at a defined position should start at that
position and 50% of all reads that start within a window
of 11 nt (5 nt upstream and downstream of the sRNA 5’
end) should start at that position. Predicted Rho-inde-
pendent terminators by
TransTermHP v2.07 (downloaded from http://trans
term.cbcb.umd.edu/tt/Streptococcus_pyogenes_M1_
GAS.tt) were analyzed.
In silico analysis of sRNAs
All sRNAs predicted by visual inspection of the sRNA
sequencing data were compared to the Rfam database,
using the RFAM web service79 to identify RNAs with
known functions. For five sRNAs with defined 5’ and 3’
ends, the structure of the sRNA was predicted with
RNAfold (v. Two.1.1)64 using settings (-p -d2 –noLP).
Regions of 100 nt upstream of the visually identified
sRNAs were extracted and analyzed using MEME (v
4.9.1) to identify putative promoter motifs. We used
FIMO (v 4.9.1) to search for these motifs upstream of
the sRNAs identified by bioinformatics analysis of the
sRNA sequencing data. Homologues in other species
were identified using BLAST (v.2.28C)80,81 against all
whole RefSeq streptococcal genomes available. The
sequences were downloaded from NCBI (ftp://ftp.ncbi.
nih.gov/genomes/Bacteria/). sRNA homologues in other
species were aligned using MAFFT (mafft-ginsi)
(v7.220).82
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